Janet MJ Hammond

Insider Reports History

Location
Boston, MA
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Janet Hammond
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Janet MJ Hammond:

Company Role Class Num Shares Value Price $ Report Date Ownership
Atea Pharmaceuticals, Inc. Chief Development Officer Common Stock 127,665 $541,299 $4.24 31 Jan 2026 Direct
Atea Pharmaceuticals, Inc. Chief Development Officer Restricted Stock Units 0 $34,425 $3.06 31 Jan 2026 Direct
Atea Pharmaceuticals, Inc. Chief Development Officer Stock Option (Right to Buy) 177,000 31 Jan 2026 Direct

Insider Reports Filed by Janet MJ Hammond

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AVIR Atea Pharmaceuticals, Inc. 31 Jan 2026 5 -$59,937 4 Chief Development Officer 03 Feb 2026, 19:46
AVIR Atea Pharmaceuticals, Inc. 31 Jan 2025 6 -$43,250 4 Chief Development Officer 04 Feb 2025, 18:00
AVIR Atea Pharmaceuticals, Inc. 31 Jan 2024 4 -$53,913 4 Chief Development Officer 02 Feb 2024, 21:24
AVIR Atea Pharmaceuticals, Inc. 31 Jan 2023 2 $0 4 Chief Development Officer 02 Feb 2023, 17:28
AVIR Atea Pharmaceuticals, Inc. 31 Jan 2022 1 $0 4 Chief Development Officer 02 Feb 2022, 16:15